The Minnesota Pollution Control Agency (MPCA) has filed a new lawsuit against 3M, alleging persistent PFAS contamination from its Cottage Grove facility. The MPCA is seeking civil penalties and further cleanup, claiming 3M has not adequately addressed past contamination. 3M, in turn, argues that some pollution stems from its work for the U.S. military and has requested the case be moved to federal court.

Bank of America Corp. (BAC) has seen increased institutional interest following a strong quarterly earnings report, which included an EPS of $1.11 on $30.27 billion in revenue and a declared quarterly dividend of $0.28 per share. Virginia Retirement Systems significantly boosted its stake, reflecting confidence in the bank's diversified business model. Analysts maintain a "Moderate Buy" consensus with an average target price of $61.06, underscoring positive market sentiment for the stock.

Verisign stock (VRSN) saw a 6.67% surge on July 25, 2025, closing at $305.79, indicating a break from its short-term downtrend and triggering buy signals from moving averages. The company, which exclusively manages .com and .net domain names, benefits from a stable, high-margin business model and is supported by strong technical indicators and its position in critical internet infrastructure. This performance, along with consistent monthly gains in May 2026, highlights its technical strength and stability for investors focused on tech defensives.

Franklin Templeton (Franklin Resources) announced a strategic collaboration with Payward, the parent company of Kraken, on May 12, 2026. This partnership aims to advance tokenized assets and institutional digital offerings, signaling the asset manager's deeper engagement in the crypto market. The initiative leverages Payward's xStocks framework to provide institutional clients with access to tokenized securities and digital assets, aligning with broader industry trends towards blockchain-based investment solutions.

Boston Scientific Corp. stock recently hit a 52-week low of $53.10 despite reporting robust first-quarter 2026 revenue of $5.2 billion, an 11.6% increase year-over-year. The company specializes in developing and marketing medical devices, with strong performance in its cardiovascular and electrophysiology segments. Despite market pressures, its NYSE listing provides US investors access to the innovative medtech sector.

Bernstein analyst Lance Wilkes maintained an "Outperform" rating for CVS Health (CVS) and raised its price target from $94.00 to $106.00, representing a 12.77% increase. Despite this positive analyst sentiment, GuruFocus assesses CVS as 25.3% overvalued with a GF Value™ of $77.66 against a current price of $97.34. The company has a strong GF Score™ of 81/100, but recent insider activity shows $6.2 million in share sales over the last three months, suggesting potential insider concerns about valuation.

Elevance Health shareholders re-elected three directors, approved executive compensation, and ratified Ernst & Young LLP as the independent auditor at their annual meeting on May 13, 2026. They also rejected a proposal to limit partisan political contributions. TipRanks' AI Analyst, Spark, rates ELV as "Outperform" citing solid financial performance and reasonable valuation, despite some industry pressures.

Las Vegas Sands (LVS) has successfully completed a $1 billion public debt offering, issuing senior notes due in 2031 and 2033. The proceeds will be used to refinance existing $1 billion notes maturing in August 2026, extending the company’s debt maturity profile and covering transaction expenses. Analysts currently hold a Neutral outlook on LVS stock, citing improved operating results but also noting balance-sheet leverage and bearish technicals.

CMS Energy and Consumers Energy shareholders recently approved all director nominees and management proposals at their annual meetings. CMS Energy investors specifically approved amendments to double authorized common stock and to allow shareholders to call special meetings, while rejecting a proposal for expanded written-consent powers. An analyst maintains a Buy rating on CMS with an $82 price target, though TipRanks’ AI Analyst, Spark, rates CMS as Neutral due to stable earnings balanced by high debt and negative free cash flow.

Expeditors International reported strong first-quarter earnings, with an EPS of $1.71, exceeding consensus by $0.38, and a 4.4% rise in revenue year-over-year. Despite a consensus "Hold" rating from analysts with an average price target indicating an 11.6% downside, the company's stock has shown a 4.1% year-to-date gain and reflects investor confidence due to its market position and operational results. The logistics leader continues to navigate a recovering market, leveraging its global network and service offerings.